Characteristic | Frequency | Associated MLGs |
---|---|---|
Severity of neurological response | ||
 Mild (13–15) | 19 (82.6%) | 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17 |
 Moderate (9–12) | 3 | 11,13,14 |
 Severe (≤ 8) | 1 | 4 |
Disease duration (months) | ||
 < 1 | 14 (63.6%) | 4,5,9,12,13,14,16,17 |
 1–3 | 7 | 1,2,3,6,8,10,11 |
 > 3 | 1 | 4 |
Clinical presentation | ||
 Fever | ||
  Yes | 24 (100%) | 1,2,3,4,5,6,7,8,9,10,11,12,13,14,16,17 |
  No | 0 |  |
 Headache | ||
  Yes | 22 (91.7%) | 1,2,3,4,5,7,8,9,10,11,12,13,14,15 |
  No | 2 | 9,17 |
 Hepatomegaly | ||
  Yes | 2 (8.3%) | 4,5 |
  No | 22 | 1,2,3,4,6,7,8,9,10,11,12,13,14,15,16,17 |
 Lymphadenopathy | ||
  Yes | 8 (33.3%) | 2,4,9,10,13,14,15 |
  No | 16 | 1,3,4,5,6,7,8,9,11,12,13,14,15,16,17 |
 Splenomegaly | ||
  Yes | 6 (25%) | 4,5,9,13,14,16 |
  No | 18 | 1,2,3,4,6,7,8,9,10,11,12,13,14,15,17 |
 Edema | ||
  Yes | 4 (16.7%) | 4,13,16 |
  No | 20 | 1,2,3,4,5,5,6,7,8,9,10,11,12,13,14,15,17 |
 Somnolence | ||
  Yes | 9 (37.5%) | 1,2,3,5,6,8,9,10,12 |
  No | 15 | 2,4,7,11,13,14,15,16,17 |
 Gait abnormalities | ||
  Yes | 6 (25%) | 1,4,13,9,11 |
  No | 18 | 2,3,4,5,6,7,8,9,10,12,13,14,15,16,17 |
 Tremors | ||
  Yes | 2 (8.3%) | 11,15 |
  No | 22 | 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17 |
 Urinary incontinence | ||
  Yes | 2 (8.3%) | 4,11 |
  No | 22 | 1,2,3,4,5,6,7,8,9,10, 12,13,14,15,16,17 |
 Cranioneuropathy | ||
  Yes | 3 (15%) | 14,15 |
  No | 20 | 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 |